Boston Partners raised its holdings in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report) by 5.4% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,024,899 shares of the company’s stock after purchasing an additional 153,920 shares during the quarter. Boston Partners’ holdings in Aveanna Healthcare were worth $37,450,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in AVAH. Sterling Capital Management LLC increased its holdings in Aveanna Healthcare by 398.3% in the 3rd quarter. Sterling Capital Management LLC now owns 2,636 shares of the company’s stock valued at $33,000 after purchasing an additional 2,107 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in Aveanna Healthcare by 217.1% during the third quarter. Farther Finance Advisors LLC now owns 2,978 shares of the company’s stock worth $37,000 after purchasing an additional 2,039 shares in the last quarter. C M Bidwell & Associates Ltd. acquired a new stake in shares of Aveanna Healthcare in the second quarter valued at $69,000. Freestone Grove Partners LP purchased a new stake in shares of Aveanna Healthcare in the 2nd quarter valued at $73,000. Finally, GK Wealth Management LLC purchased a new stake in shares of Aveanna Healthcare in the 3rd quarter valued at $90,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages recently commented on AVAH. Weiss Ratings upgraded Aveanna Healthcare from a “buy (b-)” rating to a “buy (b)” rating in a report on Friday, November 13th. Raymond James Financial reaffirmed a “strong-buy” rating on shares of Aveanna Healthcare in a report on Thursday, November 12th. Barclays increased their price objective on shares of Aveanna Healthcare from $9.50 to $15.00 and gave the company an “overweight” rating in a research report on Friday, August 28th. Royal Bank Of Canada reissued an “outperform” rating on shares of Aveanna Healthcare in a research report on Friday, November 13th. Finally, Truist Financial raised their price objective on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the company a “hold” rating in a report on Monday, August 24th. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, Aveanna Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $14.25.
Get Our Latest Stock Analysis on AVAH
Aveanna Healthcare Trading Up 2.9%
AVAH opened at $11.01 on Friday. The company has a debt-to-equity ratio of 3.80, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a one year low of $5.93 and a one year high of $14.71. The company has a market cap of $2.40 billion, a P/E ratio of 8.04, a PEG ratio of 0.75 and a beta of 2.03. The business’s 50-day simple moving average is $12.75 and its 200-day simple moving average is $9.53.
Aveanna Healthcare (NASDAQ:AVAH – Get Free Report) last announced its quarterly earnings results on Thursday, November 12th. The company reported $0.23 earnings per share for the quarter, beating analysts’ consensus estimates of $0.21 by $0.02. Aveanna Healthcare had a net margin of 11.44% and a return on equity of 63.61%. The firm had revenue of $695.54 million during the quarter, compared to analysts’ expectations of $679.48 million. As a group, equities research analysts expect that Aveanna Healthcare Holdings Inc. will post 0.75 EPS for the current fiscal year.
About Aveanna Healthcare
Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities. The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.
Featured Stories
- Five stocks we like better than Aveanna Healthcare
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
- Lazard’s New ETF Targets Monthly Income With Junk Bonds
Want to see what other hedge funds are holding AVAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH – Free Report).
Receive News & Ratings for Aveanna Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aveanna Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
